Nature Communications (Jan 2022)

A propolis-derived small molecule ameliorates metabolic syndrome in obese mice by targeting the CREB/CRTC2 transcriptional complex

  • Yaqiong Chen,
  • Jiang Wang,
  • Yibing Wang,
  • Pengfei Wang,
  • Zan Zhou,
  • Rong Wu,
  • Qian Xu,
  • Hanyun You,
  • Yaxin Liu,
  • Lei Wang,
  • Lingqin Zhou,
  • Yuting Wu,
  • Lihong Hu,
  • Hong Liu,
  • Yi Liu

DOI
https://doi.org/10.1038/s41467-021-27533-9
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 20

Abstract

Read online

Disruption of CREB/CRTC2, a key gluconeogenic transcriptional complex, has been shown to ameliorate insulin resistance in mice. Here, the authors show that the inhibitor artipllin C and the synthetic compound A57, which presents with higher inhibitory activity, improve insulin sensitivity in obese mice by inhibiting CREB-CRTC2 interaction.